This talks delivered by Dr Ee Ling Heng focuses on the transcatheter treatments options for valvular heart disease.
Learning Objectives
Dr Ee Ling Heng Background
Dr Ee Ling Heng, consultant cardiologist in adult congenital heart disease and structural intervention at the Royal Brompton and Harefield hospitals.
Dr Ee Ling Heng graduated from Imperial College London, with an intercalated BSc in Healthcare Management. She was awarded a British Heart Foundation Clinical Research Training Fellowship and completed her PhD investigating ‘Improved Outcome Prediction in Tetralogy of Fallot’.
Dr Ee Ling Heng has clinical expertise encompassing adult congenital heart disease and general cardiology. She has a special interest in structural and ACHD interventional procedures.
This talks delivered by Dr Ee Ling Heng focuses on the transcatheter treatments options for valvular heart disease.
Learning Objectives
Dr Ee Ling Heng Background
Dr Ee Ling Heng, consultant cardiologist in adult congenital heart disease and structural intervention at the Royal Brompton and Harefield hospitals.
Dr Ee Ling Heng graduated from Imperial College London, with an intercalated BSc in Healthcare Management. She was awarded a British Heart Foundation Clinical Research Training Fellowship and completed her PhD investigating ‘Improved Outcome Prediction in Tetralogy of Fallot’.
Dr Ee Ling Heng has clinical expertise encompassing adult congenital heart disease and general cardiology. She has a special interest in structural and ACHD interventional procedures.
This Grand Round focuses on the current state of atrial fibrillation in 2024 and the future challenges we might face to meet the needs and expectations of patients affected by atrial fibrillation.
Learning Objectives
Professor Gerhard Hindricks background
Prof. Gerhard Hindricks headed the Heart Center in Leipzig until February 2023 when he was appointed Head of Electrophysiology-Rhythmology at the German Heart Center of Charité, and Chief Integration Officer of the German Heart Center Berlin in March 2023. His main responsibilities in Berlin are the development of excellence in electro-physiology at Charité hospitals, the integration of the Charité hospitals to the German Heart Centre (as Chief Integration Officer) and to support the German Heart Centre of the Charité in fields of strategic development.
This Grand Round explores a European collaborative study around childhood interstitial lung disease in survivors in adulthood.
Learning Objectives
Professor Effrosyni D. Manali
Effrosyni D. Manali is Associate Professor in Athens Medical School, National and Kapodistrian University of Athens, Greece. She had completed her fellowship in Athens, Greece; Paris, France and in Cleveland, USA. She works at the 2nd Pulmonary Medicine Department of General University Hospital “Attikon”. She is the author of more than 130 peer-review articles, 19 chapter-books and participates yearly in Graduate and Postgraduate courses in Pulmonary Medicine and Internal Medicine for students and fellows. She has special interest in rare diseases of the lungs and in interstitial lung
diseases; more specifically in the study of Greek adult and pediatric patients with inheritable pulmonary fibrosis. For that purpose, she is collaborating with expert centers of excellence in Europe. She co-chaired the European Respiratory Society Task Force on transition of pediatric patients with interstitial lung disease to the adult care.
This talk focuses on endothelial studies focusing on patients with chronic lung disorders such as COPD or IPF.
Learning objectives
Dr Koralia Paschalaki Background
Koralia Paschalaki is a respiratory physician and Senior Clinical Research Fellow at the National Heart and Lung Institute. Her research is focused on the molecular mechanisms of endothelial dysfunction and vascular disease in patients with chronic lung disorders, including COPD and IPF. Using circulating endothelial progenitors, she has provided the first evidence of accelerated endothelial ageing (senescence) due to epigenetic dysfunction in patients with COPD, providing novel insights into the development of cardiovascular disease in this group. Her research work, employing primary endothelial cells and advanced organ-on-a-chip platforms, is currently funded by BHF, NIHR Biomedical Research Centre and pharma.
This Grand Round focuses on Antenatal onset adenocarcinoma treated on ECMO and it is delivered by Professor Andrew Bush, Professor Clair Hogg and Dr Michele Arigliani.
Professor Andrew Bush has research interests that include the invasive and non-invasive measurement of airway inflammation in children, in particular the use of endobronchial biopsy in the management of severe asthma, and clinical physiology, especially respiratory mass spectrometry.
Professor Claire Hogg is a leader in clinical research in PCD and novel diagnostics. Many new techniques, including 3-dimensional electron tomography and the validation of immunofluorescence for the diagnosis of PCD, have been developed in her research group and under her supervision. Her group is the first in the world to introduce the use of Artificial Intelligence to assist the diagnosis of PCD.
Dr Michele Arigliani is a paediatric respiratory fellow at RBH. His research interests are mostly focused on lung physiology and respiratory complications in children born preterm and in those with sickle cell disease. He has co-authored over 30 papers in peer-reviewed journals.
This talk by Dr Wala Mattar, focuses on what GPs and primary care should be aware of and when they should consider referring patients to the heart failure services.
Learning objectives:
Dr Wala Mattar Background
Dr Wala Mattar is a consultant cardiologist, appointed at Watford General and Harefield Hospital in 2018.
Prior to this, Dr Mattar qualified from the Arabian Gulf University in the Kingdom of Bahrain in 2004, then specialised in internal medicine and cardiology. In 2011, she came to the UK to train in cardiology at Harefield Hospital. Her subspecialty interest is coronary and structural intervention and permanent pacemakers’ insertion.
The webinar focuses on cardiac MRI guideline indications in patients with cardiovascular disease. It uses clinical cases to illustrate the role of cardiac MRI in identifying a final diagnosis, guide management and inform diagnosis. The spectrum of pathologies discussed spans from ischemic heart disease, chest pain, myocarditis, heart failure and various non-ischemic cardiomyopathic process, as well as hypertension.
Professor Chiara Bucciarelli-Ducci Background
Professor Bucciarelli-Ducci received her undergraduate degree (2001) and postgraduate fellowship in cardiology (2005) from the University of Rome “La Sapienza”, Italy.
She then undertook courses and fellowships at Northwestern University in Chicago, University of Zurich, Harvard Medical School, Oxford University and more recently an MSc in Health Economics from LSE. She worked at the Royal Brompton Hospital as a senior CMR clinical and research fellow in 2006-2010 and in 2012 she was awarded a PhD in CMR from the National Heart and Lung Institute, Imperial College.
She was appointed a consultant cardiologist at the Bristol Heart Institute and University of Bristol where she was headhunted in 2010 to build the CMR programme. In 2021 she then returned to Royal Brompton and Harefield Hospitals to lead the CMR clinical academic programme at Harefield.
This Grand Round delivered by Professor Nicholas Simmonds covers Cystic Fibrosis diagnosis and CFTR function.
More specifically this Grand Round covers:
Professor Nicholas Simmonds Background
Professor Nicholas Simmonds is Associate Director of the Adult CF Centre at Brompton and Professor of Practice (Respiratory Medicine) at Imperial College London. His main research interests include difficult CF diagnosis and the investigation of novel CF therapies. He has been a Principal Investigator on numerous global multicentre trials and is on the Executive Committee of the European Cystic Fibrosis Society (ECFS) Clinical Trials Network. He has extensive experience of novel diagnostic techniques and is the Vice Coordinator of the ECFS Diagnostic Network. He is also on the Registry Research Committee of the UK CF Registry, a role which promotes the use of registries to better understand outcomes in CF.
This Grand Round presented by Dr Stanley Hazen focuses on the microbiome: how the gut speaks to the heart.
Dr Stanley Hazen Background
Dr. Stanley Hazen received his clinical training in Internal Medicine and sub specialty training in Diabetes, Endocrinology and Metabolism at Barnes/Jewish Hospital, and a PhD in Biophysical Chemistry and Molecular Biology from Washington University School of Medicine, St. Louis, MO. He holds multiple leadership positions at the Cleveland Clinic including chair, Department of Cardiovascular & Metabolic Sciences, co-section head, Preventive Cardiology & Rehabilitation, and Director, Center for Microbiome & Human Health.
Dr. Hazen is an elected fellow to both the National Academy of Medicine, USA, and the American Association for the Advancement of Science. He also is an elected member of the American Association
of Physicians
Focusing on all aspects of general cardiology and how to manage patients and when to refer.
Learning objectives:
Dr Sohaib Nazir Background
Dr Sohaib Nazir is a consultant cardiologist at Royal Brompton Hospital and clinical senior lecturer at King’s College London. Dr Nazir specialises in all aspects of general adult cardiology such as chest pain, breathlessness, palpitations, and general health checks for cardiovascular risk factor modification.
He has a specialist interest in heart failure and cardio-oncology – notably he is one of the few clinicians in the UK who are accredited by the International Cardio-Oncology Society, and the Royal Brompton Hospital is one of two centres in the UK with Gold accreditation by this society.
Focusing on prevention approaches in COPD (including inhaled and non-inhaled advanced therapies, use of eosinophil biomarkers etc), approaches to distinguishing viral from bacterial infections (with associated implications for antibiotic stewardship) and an update on current understanding and approaches to managing long COVID syndromes.
Learning objectives:
Dr Aran Singanayagam Background
Dr Aran Singanayagam completed his medical training at the University of Edinburgh in 2005 achieving distinction in his final examinations alongside a first-class intercalated BSc in physiology. He trained as a respiratory doctor within north-west London, primarily at St Mary’s, Royal Brompton and Harefield hospitals.
This Grand Round presented by Dr Guy Scadding explores penicillin allergy de-labelling.